Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Reg'Activ is a specialized biotechnology and nutraceutical brand focused on the commercialization of the patented probiotic strain Lactobacillus fermentum ME-3. Discovered at the University of Tartu, this unique strain is clinically proven to produce glutathione, a critical endogenous antioxidant, within the human gut. The company's product portfolio includes targeted formulations for cardiovascular health, liver detoxification, and immune system support. Reg'Activ operates as a business unit of VF Bioscience, leveraging extensive clinical research to provide high-efficacy microbial therapies. Its products are distributed globally, with a significant presence in the North American market through partnerships with Essential Formulas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Reg'Activ.